What is the Cost Effectiveness of High-Dose Statin Therapy in High-Risk Patients with Coronary Artery Disease? Recent clinical trials found that high-dose statin therapy, compared with conventional-dose statin therapy, reduces the risk of cardiovascular events in patients with acute coronary syndromes (ACS) and stable coronary artery disease (CAD). However, the actual benefits and cost-effectiveness of high-dose statin therapy are still unknown. What can we deduct from this analysis, and will it affect how and when we prescribe high-does statins to our patients?
Main Findings and Implications of "Cost Effectiveness of High-Dose Statin Therapy in High-Risk Patients with Coronary Artery Disease" Study
Restart
Resume
Transcript
Main Findings and Implications of "Cost Effectiveness of High-Dose Statin Therapy in High-Risk Patients with Coronary Artery Disease" Study
closeShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
What is the Cost Effectiveness of High-Dose Statin Therapy in High-Risk Patients with Coronary Artery Disease? Recent clinical trials found that high-dose statin therapy, compared with conventional-dose statin therapy, reduces the risk of cardiovascular events in patients with acute coronary syndromes (ACS) and stable coronary artery disease (CAD). However, the actual benefits and cost-effectiveness of high-dose statin therapy are still unknown. What can we deduct from this analysis, and will it affect how and when we prescribe high-does statins to our patients?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?